nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—Metaraminol—Phenylpropanolamine—obesity	0.318	1	CrCrCtD
Phenylephrine—MAOA—Phentermine—obesity	0.0935	0.182	CbGbCtD
Phenylephrine—MAOA—Phenylpropanolamine—obesity	0.0892	0.174	CbGbCtD
Phenylephrine—MAOA—Methamphetamine—obesity	0.0748	0.146	CbGbCtD
Phenylephrine—ADRA1B—Phendimetrazine—obesity	0.0669	0.13	CbGbCtD
Phenylephrine—ADRA1A—Phendimetrazine—obesity	0.0528	0.103	CbGbCtD
Phenylephrine—ADRA1A—Benzphetamine—obesity	0.04	0.078	CbGbCtD
Phenylephrine—ADRA1A—Phenylpropanolamine—obesity	0.0382	0.0744	CbGbCtD
Phenylephrine—CYP1A2—Phentermine—obesity	0.0169	0.0328	CbGbCtD
Phenylephrine—CYP1A2—Phenylpropanolamine—obesity	0.0161	0.0313	CbGbCtD
Phenylephrine—CYP1A2—Bupropion—obesity	0.0143	0.0279	CbGbCtD
Phenylephrine—CYP1A2—Cimetidine—obesity	0.0105	0.0205	CbGbCtD
Phenylephrine—Isoprenaline—PIK3R1—obesity	0.000667	0.166	CrCbGaD
Phenylephrine—Myocardial infarction—Phentermine—obesity	0.000667	0.00781	CcSEcCtD
Phenylephrine—Agitation—Benzphetamine—obesity	0.000656	0.00768	CcSEcCtD
Phenylephrine—Palpitations—Methamphetamine—obesity	0.000654	0.00766	CcSEcCtD
Phenylephrine—Sweating increased—Diethylpropion—obesity	0.000646	0.00758	CcSEcCtD
Phenylephrine—Palpitations—Benzphetamine—obesity	0.00063	0.00739	CcSEcCtD
Phenylephrine—Vision blurred—Phendimetrazine—obesity	0.000613	0.00718	CcSEcCtD
Phenylephrine—Tremor—Phendimetrazine—obesity	0.000609	0.00714	CcSEcCtD
Phenylephrine—Agitation—Phendimetrazine—obesity	0.000598	0.007	CcSEcCtD
Phenylephrine—Ventricular extrasystoles—Sibutramine—obesity	0.000595	0.00698	CcSEcCtD
Phenylephrine—Tachycardia—Methamphetamine—obesity	0.000589	0.00691	CcSEcCtD
Phenylephrine—Mydriasis—Bupropion—obesity	0.000588	0.00689	CcSEcCtD
Phenylephrine—Palpitations—Phendimetrazine—obesity	0.000575	0.00673	CcSEcCtD
Phenylephrine—Arrhythmia—Phenylpropanolamine—obesity	0.00057	0.00668	CcSEcCtD
Phenylephrine—Tachycardia—Benzphetamine—obesity	0.000568	0.00666	CcSEcCtD
Phenylephrine—Pallor—Bupropion—obesity	0.000566	0.00663	CcSEcCtD
Phenylephrine—Hyperhidrosis—Benzphetamine—obesity	0.000563	0.0066	CcSEcCtD
Phenylephrine—Extrasystoles—Bupropion—obesity	0.000557	0.00653	CcSEcCtD
Phenylephrine—Tension—Phenylpropanolamine—obesity	0.000545	0.00639	CcSEcCtD
Phenylephrine—Neck pain—Sibutramine—obesity	0.000544	0.00638	CcSEcCtD
Phenylephrine—Nervousness—Phenylpropanolamine—obesity	0.000539	0.00632	CcSEcCtD
Phenylephrine—Blood pressure increased—Sibutramine—obesity	0.000538	0.0063	CcSEcCtD
Phenylephrine—Vision blurred—Phenylpropanolamine—obesity	0.000523	0.00614	CcSEcCtD
Phenylephrine—Tension—Phentermine—obesity	0.000522	0.00611	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Methamphetamine—obesity	0.000521	0.00611	CcSEcCtD
Phenylephrine—Tremor—Phenylpropanolamine—obesity	0.00052	0.0061	CcSEcCtD
Phenylephrine—Tachycardia—Phendimetrazine—obesity	0.000518	0.00607	CcSEcCtD
Phenylephrine—Nervousness—Phentermine—obesity	0.000516	0.00605	CcSEcCtD
Phenylephrine—Bradycardia—Cimetidine—obesity	0.000515	0.00603	CcSEcCtD
Phenylephrine—Hyperhidrosis—Phendimetrazine—obesity	0.000513	0.00601	CcSEcCtD
Phenylephrine—Agitation—Phenylpropanolamine—obesity	0.00051	0.00598	CcSEcCtD
Phenylephrine—Lacrimation increased—Bupropion—obesity	0.000509	0.00596	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Benzphetamine—obesity	0.000503	0.00589	CcSEcCtD
Phenylephrine—Tremor—Phentermine—obesity	0.000498	0.00584	CcSEcCtD
Phenylephrine—Agitation—Phentermine—obesity	0.000488	0.00573	CcSEcCtD
Phenylephrine—Urticaria—Methamphetamine—obesity	0.00048	0.00562	CcSEcCtD
Phenylephrine—Arrhythmia—Diethylpropion—obesity	0.000475	0.00556	CcSEcCtD
Phenylephrine—Neck pain—Bupropion—obesity	0.000475	0.00556	CcSEcCtD
Phenylephrine—Palpitations—Phentermine—obesity	0.00047	0.00551	CcSEcCtD
Phenylephrine—Blood pressure increased—Bupropion—obesity	0.000469	0.00549	CcSEcCtD
Phenylephrine—Urticaria—Benzphetamine—obesity	0.000463	0.00542	CcSEcCtD
Phenylephrine—Hypertension—Phentermine—obesity	0.000459	0.00538	CcSEcCtD
Phenylephrine—Tension—Diethylpropion—obesity	0.000454	0.00532	CcSEcCtD
Phenylephrine—Chest pain—Phentermine—obesity	0.000453	0.0053	CcSEcCtD
Phenylephrine—Nervousness—Diethylpropion—obesity	0.000449	0.00526	CcSEcCtD
Phenylephrine—Hypersensitivity—Methamphetamine—obesity	0.000445	0.00521	CcSEcCtD
Phenylephrine—Tachycardia—Phenylpropanolamine—obesity	0.000442	0.00519	CcSEcCtD
Phenylephrine—Photophobia—Bupropion—obesity	0.00044	0.00516	CcSEcCtD
Phenylephrine—Vision blurred—Diethylpropion—obesity	0.000436	0.00511	CcSEcCtD
Phenylephrine—Tremor—Diethylpropion—obesity	0.000433	0.00508	CcSEcCtD
Phenylephrine—Eye pain—Sibutramine—obesity	0.000432	0.00507	CcSEcCtD
Phenylephrine—Hypersensitivity—Benzphetamine—obesity	0.000429	0.00503	CcSEcCtD
Phenylephrine—Agitation—Diethylpropion—obesity	0.000425	0.00498	CcSEcCtD
Phenylephrine—Tachycardia—Phentermine—obesity	0.000423	0.00496	CcSEcCtD
Phenylephrine—Palpitations—Diethylpropion—obesity	0.000409	0.00479	CcSEcCtD
Phenylephrine—Agitation—Cimetidine—obesity	0.000404	0.00474	CcSEcCtD
Phenylephrine—Dyspnoea—Phenylpropanolamine—obesity	0.000404	0.00474	CcSEcCtD
Phenylephrine—Dizziness—Methamphetamine—obesity	0.000399	0.00468	CcSEcCtD
Phenylephrine—Chest pain—Diethylpropion—obesity	0.000394	0.00461	CcSEcCtD
Phenylephrine—Dizziness—Benzphetamine—obesity	0.000385	0.00451	CcSEcCtD
Phenylephrine—Headache—Methamphetamine—obesity	0.000378	0.00443	CcSEcCtD
Phenylephrine—Eye pain—Bupropion—obesity	0.000377	0.00442	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Phentermine—obesity	0.000375	0.00439	CcSEcCtD
Phenylephrine—Mydriasis—Topiramate—obesity	0.000375	0.00439	CcSEcCtD
Phenylephrine—Abdominal pain upper—Orlistat—obesity	0.000368	0.00432	CcSEcCtD
Phenylephrine—Tachycardia—Diethylpropion—obesity	0.000368	0.00432	CcSEcCtD
Phenylephrine—Hyperhidrosis—Diethylpropion—obesity	0.000365	0.00428	CcSEcCtD
Phenylephrine—Headache—Benzphetamine—obesity	0.000365	0.00428	CcSEcCtD
Phenylephrine—Pallor—Topiramate—obesity	0.00036	0.00422	CcSEcCtD
Phenylephrine—Visual disturbance—Bupropion—obesity	0.000359	0.00421	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Sibutramine—obesity	0.000357	0.00418	CcSEcCtD
Phenylephrine—Edrophonium—BCHE—obesity	0.000352	0.0874	CrCbGaD
Phenylephrine—Dizziness—Phendimetrazine—obesity	0.000351	0.00411	CcSEcCtD
Phenylephrine—Tachycardia—Cimetidine—obesity	0.00035	0.00411	CcSEcCtD
Phenylephrine—Orciprenaline—ADRB2—obesity	0.000349	0.0866	CrCbGaD
Phenylephrine—Nausea—Benzphetamine—obesity	0.000346	0.00405	CcSEcCtD
Phenylephrine—Urticaria—Phentermine—obesity	0.000345	0.00404	CcSEcCtD
Phenylephrine—Sweating increased—Orlistat—obesity	0.00034	0.00398	CcSEcCtD
Phenylephrine—Dyspnoea—Diethylpropion—obesity	0.000336	0.00394	CcSEcCtD
Phenylephrine—Hypersensitivity—Phenylpropanolamine—obesity	0.000334	0.00391	CcSEcCtD
Phenylephrine—Headache—Phendimetrazine—obesity	0.000332	0.0039	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Diethylpropion—obesity	0.000326	0.00382	CcSEcCtD
Phenylephrine—Lacrimation increased—Topiramate—obesity	0.000324	0.0038	CcSEcCtD
Phenylephrine—Nausea—Phendimetrazine—obesity	0.000315	0.00369	CcSEcCtD
Phenylephrine—Abdominal pain upper—Bupropion—obesity	0.000311	0.00364	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Bupropion—obesity	0.000311	0.00364	CcSEcCtD
Phenylephrine—Atrioventricular block—Topiramate—obesity	0.000308	0.00361	CcSEcCtD
Phenylephrine—Urticaria—Diethylpropion—obesity	0.0003	0.00351	CcSEcCtD
Phenylephrine—Dizziness—Phenylpropanolamine—obesity	0.0003	0.00351	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Sibutramine—obesity	0.000297	0.00348	CcSEcCtD
Phenylephrine—Myocardial infarction—Sibutramine—obesity	0.000295	0.00346	CcSEcCtD
Phenylephrine—Vomiting—Phenylpropanolamine—obesity	0.000288	0.00338	CcSEcCtD
Phenylephrine—Dizziness—Phentermine—obesity	0.000287	0.00336	CcSEcCtD
Phenylephrine—Sweating increased—Bupropion—obesity	0.000287	0.00336	CcSEcCtD
Phenylephrine—Rash—Phenylpropanolamine—obesity	0.000286	0.00335	CcSEcCtD
Phenylephrine—Dermatitis—Phenylpropanolamine—obesity	0.000286	0.00335	CcSEcCtD
Phenylephrine—Photophobia—Topiramate—obesity	0.00028	0.00329	CcSEcCtD
Phenylephrine—Vomiting—Phentermine—obesity	0.000276	0.00323	CcSEcCtD
Phenylephrine—Bradycardia—Sibutramine—obesity	0.000275	0.00322	CcSEcCtD
Phenylephrine—Rash—Phentermine—obesity	0.000274	0.00321	CcSEcCtD
Phenylephrine—Dermatitis—Phentermine—obesity	0.000273	0.0032	CcSEcCtD
Phenylephrine—Headache—Phentermine—obesity	0.000272	0.00319	CcSEcCtD
Phenylephrine—Nausea—Phenylpropanolamine—obesity	0.000269	0.00316	CcSEcCtD
Phenylephrine—Terbutaline—BCHE—obesity	0.000267	0.0662	CrCbGaD
Phenylephrine—Hypersensitivity—Cimetidine—obesity	0.000265	0.0031	CcSEcCtD
Phenylephrine—Visual impairment—Sibutramine—obesity	0.00026	0.00305	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Bupropion—obesity	0.000259	0.00303	CcSEcCtD
Phenylephrine—Nausea—Phentermine—obesity	0.000258	0.00302	CcSEcCtD
Phenylephrine—Myocardial infarction—Bupropion—obesity	0.000257	0.00301	CcSEcCtD
Phenylephrine—Immune system disorder—Orlistat—obesity	0.000252	0.00295	CcSEcCtD
Phenylephrine—Mediastinal disorder—Orlistat—obesity	0.000251	0.00295	CcSEcCtD
Phenylephrine—Dizziness—Diethylpropion—obesity	0.00025	0.00292	CcSEcCtD
Phenylephrine—Angiopathy—Sibutramine—obesity	0.000245	0.00287	CcSEcCtD
Phenylephrine—Mental disorder—Orlistat—obesity	0.000244	0.00287	CcSEcCtD
Phenylephrine—Immune system disorder—Sibutramine—obesity	0.000244	0.00286	CcSEcCtD
Phenylephrine—Arrhythmia—Sibutramine—obesity	0.000241	0.00283	CcSEcCtD
Phenylephrine—Isoprenaline—ADRB3—obesity	0.000241	0.0599	CrCbGaD
Phenylephrine—Eye pain—Topiramate—obesity	0.00024	0.00281	CcSEcCtD
Phenylephrine—Vomiting—Diethylpropion—obesity	0.00024	0.00281	CcSEcCtD
Phenylephrine—Rash—Diethylpropion—obesity	0.000238	0.00279	CcSEcCtD
Phenylephrine—Dysgeusia—Orlistat—obesity	0.000238	0.00279	CcSEcCtD
Phenylephrine—Dermatitis—Diethylpropion—obesity	0.000238	0.00279	CcSEcCtD
Phenylephrine—Dizziness—Cimetidine—obesity	0.000237	0.00278	CcSEcCtD
Phenylephrine—Headache—Diethylpropion—obesity	0.000236	0.00277	CcSEcCtD
Phenylephrine—Tension—Sibutramine—obesity	0.000231	0.0027	CcSEcCtD
Phenylephrine—Dysgeusia—Sibutramine—obesity	0.00023	0.0027	CcSEcCtD
Phenylephrine—Terbutaline—ADRB2—obesity	0.000229	0.0569	CrCbGaD
Phenylephrine—Vision blurred—Orlistat—obesity	0.000229	0.00268	CcSEcCtD
Phenylephrine—Visual disturbance—Topiramate—obesity	0.000229	0.00268	CcSEcCtD
Phenylephrine—Nervousness—Sibutramine—obesity	0.000228	0.00268	CcSEcCtD
Phenylephrine—Vomiting—Cimetidine—obesity	0.000228	0.00268	CcSEcCtD
Phenylephrine—Visual impairment—Bupropion—obesity	0.000227	0.00266	CcSEcCtD
Phenylephrine—Rash—Cimetidine—obesity	0.000226	0.00265	CcSEcCtD
Phenylephrine—Dermatitis—Cimetidine—obesity	0.000226	0.00265	CcSEcCtD
Phenylephrine—Headache—Cimetidine—obesity	0.000225	0.00264	CcSEcCtD
Phenylephrine—Nausea—Diethylpropion—obesity	0.000224	0.00263	CcSEcCtD
Phenylephrine—Norepinephrine—ADRB3—obesity	0.000223	0.0554	CrCbGaD
Phenylephrine—Vision blurred—Sibutramine—obesity	0.000222	0.0026	CcSEcCtD
Phenylephrine—Tremor—Sibutramine—obesity	0.00022	0.00258	CcSEcCtD
Phenylephrine—Cardiac disorder—Bupropion—obesity	0.000218	0.00256	CcSEcCtD
Phenylephrine—Agitation—Sibutramine—obesity	0.000216	0.00253	CcSEcCtD
Phenylephrine—Palpitations—Orlistat—obesity	0.000215	0.00252	CcSEcCtD
Phenylephrine—Angiopathy—Bupropion—obesity	0.000214	0.0025	CcSEcCtD
Phenylephrine—Nausea—Cimetidine—obesity	0.000213	0.0025	CcSEcCtD
Phenylephrine—Immune system disorder—Bupropion—obesity	0.000213	0.00249	CcSEcCtD
Phenylephrine—Mediastinal disorder—Bupropion—obesity	0.000212	0.00249	CcSEcCtD
Phenylephrine—Syncope—Sibutramine—obesity	0.000211	0.00247	CcSEcCtD
Phenylephrine—Arrhythmia—Bupropion—obesity	0.00021	0.00246	CcSEcCtD
Phenylephrine—Palpitations—Sibutramine—obesity	0.000208	0.00243	CcSEcCtD
Phenylephrine—Chest pain—Orlistat—obesity	0.000207	0.00242	CcSEcCtD
Phenylephrine—Loss of consciousness—Sibutramine—obesity	0.000207	0.00242	CcSEcCtD
Phenylephrine—Mental disorder—Bupropion—obesity	0.000206	0.00242	CcSEcCtD
Phenylephrine—ADRA1A—hindbrain—obesity	0.000205	0.0987	CbGeAlD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000205	0.00241	CcSEcCtD
Phenylephrine—MAOA—hindbrain—obesity	0.000204	0.0978	CbGeAlD
Phenylephrine—Hypertension—Sibutramine—obesity	0.000203	0.00238	CcSEcCtD
Phenylephrine—Salbutamol—ADRB1—obesity	0.000203	0.0503	CrCbGaD
Phenylephrine—Epinephrine—ADRB3—obesity	0.000202	0.0503	CrCbGaD
Phenylephrine—Tension—Bupropion—obesity	0.000201	0.00236	CcSEcCtD
Phenylephrine—Dysgeusia—Bupropion—obesity	0.000201	0.00235	CcSEcCtD
Phenylephrine—Chest pain—Sibutramine—obesity	0.0002	0.00235	CcSEcCtD
Phenylephrine—Nervousness—Bupropion—obesity	0.000199	0.00233	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Topiramate—obesity	0.000198	0.00232	CcSEcCtD
Phenylephrine—Abdominal pain upper—Topiramate—obesity	0.000198	0.00232	CcSEcCtD
Phenylephrine—Nervous system disorder—Orlistat—obesity	0.000194	0.00228	CcSEcCtD
Phenylephrine—Vision blurred—Bupropion—obesity	0.000193	0.00226	CcSEcCtD
Phenylephrine—Skin disorder—Orlistat—obesity	0.000193	0.00226	CcSEcCtD
Phenylephrine—Tremor—Bupropion—obesity	0.000192	0.00225	CcSEcCtD
Phenylephrine—Hyperhidrosis—Orlistat—obesity	0.000192	0.00225	CcSEcCtD
Phenylephrine—Shock—Sibutramine—obesity	0.000189	0.00221	CcSEcCtD
Phenylephrine—Agitation—Bupropion—obesity	0.000188	0.00221	CcSEcCtD
Phenylephrine—Tachycardia—Sibutramine—obesity	0.000187	0.00219	CcSEcCtD
Phenylephrine—Skin disorder—Sibutramine—obesity	0.000186	0.00218	CcSEcCtD
Phenylephrine—Hyperhidrosis—Sibutramine—obesity	0.000185	0.00217	CcSEcCtD
Phenylephrine—Syncope—Bupropion—obesity	0.000184	0.00215	CcSEcCtD
Phenylephrine—Sweating increased—Topiramate—obesity	0.000183	0.00214	CcSEcCtD
Phenylephrine—Palpitations—Bupropion—obesity	0.000181	0.00212	CcSEcCtD
Phenylephrine—Loss of consciousness—Bupropion—obesity	0.00018	0.00211	CcSEcCtD
Phenylephrine—Paraesthesia—Orlistat—obesity	0.000178	0.00209	CcSEcCtD
Phenylephrine—Hypertension—Bupropion—obesity	0.000177	0.00207	CcSEcCtD
Phenylephrine—Chest pain—Bupropion—obesity	0.000174	0.00204	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000173	0.00203	CcSEcCtD
Phenylephrine—Paraesthesia—Sibutramine—obesity	0.000172	0.00202	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Orlistat—obesity	0.000171	0.00201	CcSEcCtD
Phenylephrine—Dyspnoea—Sibutramine—obesity	0.000171	0.002	CcSEcCtD
Phenylephrine—Salbutamol—ADRB2—obesity	0.00017	0.0423	CrCbGaD
Phenylephrine—Pain—Orlistat—obesity	0.00017	0.00199	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Sibutramine—obesity	0.000166	0.00194	CcSEcCtD
Phenylephrine—Shock—Bupropion—obesity	0.000165	0.00193	CcSEcCtD
Phenylephrine—Pain—Sibutramine—obesity	0.000164	0.00192	CcSEcCtD
Phenylephrine—Nervous system disorder—Bupropion—obesity	0.000164	0.00192	CcSEcCtD
Phenylephrine—Tachycardia—Bupropion—obesity	0.000163	0.00191	CcSEcCtD
Phenylephrine—Skin disorder—Bupropion—obesity	0.000162	0.0019	CcSEcCtD
Phenylephrine—Hyperhidrosis—Bupropion—obesity	0.000162	0.0019	CcSEcCtD
Phenylephrine—Urticaria—Orlistat—obesity	0.000157	0.00185	CcSEcCtD
Phenylephrine—Bradycardia—Topiramate—obesity	0.000153	0.00179	CcSEcCtD
Phenylephrine—Urticaria—Sibutramine—obesity	0.000152	0.00179	CcSEcCtD
Phenylephrine—Tapentadol—SLC6A4—obesity	0.000152	0.0377	CrCbGaD
Phenylephrine—Paraesthesia—Bupropion—obesity	0.00015	0.00176	CcSEcCtD
Phenylephrine—Dyspnoea—Bupropion—obesity	0.000149	0.00175	CcSEcCtD
Phenylephrine—Hypersensitivity—Orlistat—obesity	0.000146	0.00171	CcSEcCtD
Phenylephrine—Visual impairment—Topiramate—obesity	0.000145	0.00169	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Bupropion—obesity	0.000144	0.00169	CcSEcCtD
Phenylephrine—Pain—Bupropion—obesity	0.000143	0.00168	CcSEcCtD
Phenylephrine—Hypersensitivity—Sibutramine—obesity	0.000141	0.00166	CcSEcCtD
Phenylephrine—Pruritus—Orlistat—obesity	0.00014	0.00164	CcSEcCtD
Phenylephrine—Cardiac disorder—Topiramate—obesity	0.000139	0.00163	CcSEcCtD
Phenylephrine—Angiopathy—Topiramate—obesity	0.000136	0.00159	CcSEcCtD
Phenylephrine—Pruritus—Sibutramine—obesity	0.000136	0.00159	CcSEcCtD
Phenylephrine—Immune system disorder—Topiramate—obesity	0.000135	0.00159	CcSEcCtD
Phenylephrine—Mediastinal disorder—Topiramate—obesity	0.000135	0.00158	CcSEcCtD
Phenylephrine—Norepinephrine—SLC22A1—obesity	0.000133	0.033	CrCbGaD
Phenylephrine—Urticaria—Bupropion—obesity	0.000133	0.00156	CcSEcCtD
Phenylephrine—MAOA—islet of Langerhans—obesity	0.000132	0.0632	CbGeAlD
Phenylephrine—Mental disorder—Topiramate—obesity	0.000131	0.00154	CcSEcCtD
Phenylephrine—Dizziness—Orlistat—obesity	0.000131	0.00154	CcSEcCtD
Phenylephrine—Tension—Topiramate—obesity	0.000128	0.0015	CcSEcCtD
Phenylephrine—Dysgeusia—Topiramate—obesity	0.000128	0.0015	CcSEcCtD
Phenylephrine—Dizziness—Sibutramine—obesity	0.000127	0.00149	CcSEcCtD
Phenylephrine—Nervousness—Topiramate—obesity	0.000127	0.00149	CcSEcCtD
Phenylephrine—Vomiting—Orlistat—obesity	0.000126	0.00148	CcSEcCtD
Phenylephrine—Rash—Orlistat—obesity	0.000125	0.00147	CcSEcCtD
Phenylephrine—Dermatitis—Orlistat—obesity	0.000125	0.00146	CcSEcCtD
Phenylephrine—MAOA—respiratory system—obesity	0.000124	0.0597	CbGeAlD
Phenylephrine—Headache—Orlistat—obesity	0.000124	0.00146	CcSEcCtD
Phenylephrine—Hypersensitivity—Bupropion—obesity	0.000123	0.00144	CcSEcCtD
Phenylephrine—Vision blurred—Topiramate—obesity	0.000123	0.00144	CcSEcCtD
Phenylephrine—Tremor—Topiramate—obesity	0.000122	0.00143	CcSEcCtD
Phenylephrine—Vomiting—Sibutramine—obesity	0.000122	0.00143	CcSEcCtD
Phenylephrine—Rash—Sibutramine—obesity	0.000121	0.00142	CcSEcCtD
Phenylephrine—Dermatitis—Sibutramine—obesity	0.000121	0.00142	CcSEcCtD
Phenylephrine—Epinephrine—SLC22A1—obesity	0.000121	0.03	CrCbGaD
Phenylephrine—Headache—Sibutramine—obesity	0.00012	0.00141	CcSEcCtD
Phenylephrine—Agitation—Topiramate—obesity	0.00012	0.00141	CcSEcCtD
Phenylephrine—Pruritus—Bupropion—obesity	0.000118	0.00139	CcSEcCtD
Phenylephrine—Nausea—Orlistat—obesity	0.000118	0.00138	CcSEcCtD
Phenylephrine—Syncope—Topiramate—obesity	0.000117	0.00137	CcSEcCtD
Phenylephrine—Palpitations—Topiramate—obesity	0.000115	0.00135	CcSEcCtD
Phenylephrine—Loss of consciousness—Topiramate—obesity	0.000115	0.00135	CcSEcCtD
Phenylephrine—ADRA1D—endocrine gland—obesity	0.000115	0.0551	CbGeAlD
Phenylephrine—Nausea—Sibutramine—obesity	0.000114	0.00134	CcSEcCtD
Phenylephrine—Hypertension—Topiramate—obesity	0.000113	0.00132	CcSEcCtD
Phenylephrine—Chest pain—Topiramate—obesity	0.000111	0.0013	CcSEcCtD
Phenylephrine—Dizziness—Bupropion—obesity	0.000111	0.0013	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.00011	0.00129	CcSEcCtD
Phenylephrine—Isoprenaline—ADRB1—obesity	0.000109	0.0271	CrCbGaD
Phenylephrine—Vomiting—Bupropion—obesity	0.000106	0.00125	CcSEcCtD
Phenylephrine—Rash—Bupropion—obesity	0.000105	0.00124	CcSEcCtD
Phenylephrine—Dermatitis—Bupropion—obesity	0.000105	0.00123	CcSEcCtD
Phenylephrine—Shock—Topiramate—obesity	0.000105	0.00123	CcSEcCtD
Phenylephrine—Headache—Bupropion—obesity	0.000105	0.00123	CcSEcCtD
Phenylephrine—Nervous system disorder—Topiramate—obesity	0.000105	0.00122	CcSEcCtD
Phenylephrine—MAOA—adrenal cortex—obesity	0.000104	0.0501	CbGeAlD
Phenylephrine—Tachycardia—Topiramate—obesity	0.000104	0.00122	CcSEcCtD
Phenylephrine—CYP1A2—respiratory system—obesity	0.000104	0.0498	CbGeAlD
Phenylephrine—Skin disorder—Topiramate—obesity	0.000104	0.00121	CcSEcCtD
Phenylephrine—Hyperhidrosis—Topiramate—obesity	0.000103	0.00121	CcSEcCtD
Phenylephrine—Norepinephrine—ADRB1—obesity	0.000101	0.0251	CrCbGaD
Phenylephrine—Nausea—Bupropion—obesity	9.94e-05	0.00116	CcSEcCtD
Phenylephrine—ADRA1A—cardiovascular system—obesity	9.61e-05	0.0461	CbGeAlD
Phenylephrine—Paraesthesia—Topiramate—obesity	9.57e-05	0.00112	CcSEcCtD
Phenylephrine—MAOA—cardiovascular system—obesity	9.52e-05	0.0457	CbGeAlD
Phenylephrine—Dyspnoea—Topiramate—obesity	9.5e-05	0.00111	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Topiramate—obesity	9.2e-05	0.00108	CcSEcCtD
Phenylephrine—Isoprenaline—ADRB2—obesity	9.16e-05	0.0228	CrCbGaD
Phenylephrine—Epinephrine—ADRB1—obesity	9.15e-05	0.0227	CrCbGaD
Phenylephrine—Pain—Topiramate—obesity	9.11e-05	0.00107	CcSEcCtD
Phenylephrine—Epinephrine—TNF—obesity	8.69e-05	0.0216	CrCbGaD
Phenylephrine—Norepinephrine—ADRB2—obesity	8.48e-05	0.0211	CrCbGaD
Phenylephrine—ADRA1A—adipose tissue—obesity	8.47e-05	0.0407	CbGeAlD
Phenylephrine—Urticaria—Topiramate—obesity	8.47e-05	0.000992	CcSEcCtD
Phenylephrine—MAOA—pituitary gland—obesity	8.43e-05	0.0405	CbGeAlD
Phenylephrine—MAOA—adipose tissue—obesity	8.4e-05	0.0403	CbGeAlD
Phenylephrine—MAOA—digestive system—obesity	7.9e-05	0.038	CbGeAlD
Phenylephrine—Hypersensitivity—Topiramate—obesity	7.85e-05	0.00092	CcSEcCtD
Phenylephrine—Epinephrine—ADRB2—obesity	7.7e-05	0.0191	CrCbGaD
Phenylephrine—Norepinephrine—DRD2—obesity	7.66e-05	0.019	CrCbGaD
Phenylephrine—ADRA1A—adrenal gland—obesity	7.6e-05	0.0365	CbGeAlD
Phenylephrine—Pruritus—Topiramate—obesity	7.54e-05	0.000884	CcSEcCtD
Phenylephrine—MAOA—adrenal gland—obesity	7.53e-05	0.0362	CbGeAlD
Phenylephrine—Dizziness—Topiramate—obesity	7.05e-05	0.000826	CcSEcCtD
Phenylephrine—Vomiting—Topiramate—obesity	6.78e-05	0.000794	CcSEcCtD
Phenylephrine—Rash—Topiramate—obesity	6.72e-05	0.000787	CcSEcCtD
Phenylephrine—Dermatitis—Topiramate—obesity	6.71e-05	0.000787	CcSEcCtD
Phenylephrine—Headache—Topiramate—obesity	6.68e-05	0.000782	CcSEcCtD
Phenylephrine—CYP1A2—digestive system—obesity	6.59e-05	0.0317	CbGeAlD
Phenylephrine—ADRA1A—endocrine gland—obesity	6.59e-05	0.0317	CbGeAlD
Phenylephrine—MAOA—endocrine gland—obesity	6.53e-05	0.0314	CbGeAlD
Phenylephrine—Nausea—Topiramate—obesity	6.33e-05	0.000742	CcSEcCtD
Phenylephrine—ADRA1A—liver—obesity	5.94e-05	0.0285	CbGeAlD
Phenylephrine—MAOA—liver—obesity	5.89e-05	0.0283	CbGeAlD
Phenylephrine—CYP1A2—endocrine gland—obesity	5.45e-05	0.0262	CbGeAlD
Phenylephrine—CYP1A2—liver—obesity	4.91e-05	0.0236	CbGeAlD
Phenylephrine—CYP1A2—Metabolism—LPA—obesity	5.27e-06	6.86e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SOCS3—obesity	5.26e-06	6.84e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CG—obesity	5.24e-06	6.82e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PRKCD—obesity	5.2e-06	6.77e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CD—obesity	5.16e-06	6.72e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—LPIN1—obesity	5.16e-06	6.71e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GNB3—obesity	5.15e-06	6.7e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HTR2A—obesity	5.09e-06	6.63e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—C3—obesity	5.09e-06	6.62e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—TYK2—obesity	5.08e-06	6.61e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—POMC—obesity	5.08e-06	6.61e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—obesity	5.07e-06	6.59e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CB—obesity	5.07e-06	6.59e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PRL—obesity	5.06e-06	6.59e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IGF2—obesity	5.06e-06	6.58e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PPARG—obesity	5.06e-06	6.58e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOA5—obesity	5.05e-06	6.57e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—RHOA—obesity	5.04e-06	6.55e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GNAS—obesity	5.01e-06	6.52e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—STK11—obesity	4.99e-06	6.49e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—POMC—obesity	4.99e-06	6.49e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3R1—obesity	4.98e-06	6.49e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CCL2—obesity	4.97e-06	6.46e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—INS—obesity	4.96e-06	6.45e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PLG—obesity	4.93e-06	6.42e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—RHOA—obesity	4.93e-06	6.41e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APOB—obesity	4.91e-06	6.39e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—obesity	4.91e-06	6.39e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—AKT2—obesity	4.88e-06	6.35e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3R1—obesity	4.88e-06	6.34e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IRS2—obesity	4.84e-06	6.3e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AGT—obesity	4.83e-06	6.29e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CLOCK—obesity	4.82e-06	6.27e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SLC22A1—obesity	4.82e-06	6.27e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FOXO3—obesity	4.82e-06	6.27e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—obesity	4.81e-06	6.26e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ADRB2—obesity	4.8e-06	6.25e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCL5—obesity	4.8e-06	6.24e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—obesity	4.76e-06	6.2e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—obesity	4.75e-06	6.18e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—APOE—obesity	4.74e-06	6.16e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—LEP—obesity	4.74e-06	6.16e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SOCS1—obesity	4.73e-06	6.16e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SULT2A1—obesity	4.7e-06	6.11e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GLP1R—obesity	4.7e-06	6.11e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CAV1—obesity	4.69e-06	6.1e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—LPL—obesity	4.69e-06	6.1e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CD—obesity	4.69e-06	6.1e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—APOA1—obesity	4.68e-06	6.09e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SOCS3—obesity	4.67e-06	6.08e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FOXO1—obesity	4.66e-06	6.06e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RPS6KB1—obesity	4.65e-06	6.05e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—DPYD—obesity	4.62e-06	6.01e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CD—obesity	4.61e-06	5.99e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CB—obesity	4.6e-06	5.99e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GNB3—obesity	4.57e-06	5.95e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ALB—obesity	4.55e-06	5.92e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ESR1—obesity	4.52e-06	5.88e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—TYK2—obesity	4.51e-06	5.87e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CB—obesity	4.5e-06	5.86e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF2—obesity	4.49e-06	5.85e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—RHOA—obesity	4.47e-06	5.82e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—F2—obesity	4.47e-06	5.81e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PRKCB—obesity	4.47e-06	5.81e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GNAS—obesity	4.45e-06	5.8e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PRKAR2B—obesity	4.45e-06	5.79e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3R1—obesity	4.43e-06	5.76e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—DCN—obesity	4.42e-06	5.75e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—BAD—obesity	4.41e-06	5.74e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APOB—obesity	4.36e-06	5.68e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3R1—obesity	4.35e-06	5.66e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—NOS3—obesity	4.35e-06	5.66e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	4.34e-06	5.65e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PRKCD—obesity	4.32e-06	5.62e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CPT1A—obesity	4.3e-06	5.59e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CG—obesity	4.27e-06	5.56e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCL5—obesity	4.26e-06	5.54e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HTR2A—obesity	4.23e-06	5.5e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IRS1—obesity	4.22e-06	5.5e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—C3—obesity	4.22e-06	5.49e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NAMPT—obesity	4.21e-06	5.48e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—obesity	4.19e-06	5.45e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GCK—obesity	4.19e-06	5.45e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—LIPC—obesity	4.19e-06	5.45e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—LPL—obesity	4.16e-06	5.42e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOC3—obesity	4.16e-06	5.41e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FOXO1—obesity	4.13e-06	5.38e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—obesity	4.13e-06	5.37e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RPS6KB1—obesity	4.13e-06	5.37e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CB—obesity	4.09e-06	5.32e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—POMC—obesity	4.07e-06	5.29e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—INS—obesity	4.05e-06	5.26e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CETP—obesity	4.04e-06	5.26e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IRS2—obesity	4.02e-06	5.23e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CB—obesity	4.02e-06	5.22e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AGT—obesity	4.01e-06	5.22e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SDC1—obesity	3.99e-06	5.2e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCL2—obesity	3.98e-06	5.18e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTGS2—obesity	3.98e-06	5.18e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—LEP—obesity	3.93e-06	5.11e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APOE—obesity	3.93e-06	5.11e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AKR1C3—obesity	3.93e-06	5.11e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IGF1—obesity	3.91e-06	5.09e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AKT2—obesity	3.91e-06	5.09e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CAV1—obesity	3.89e-06	5.07e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APOA1—obesity	3.89e-06	5.06e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SCARB1—obesity	3.87e-06	5.03e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PRKCD—obesity	3.84e-06	4.99e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	3.81e-06	4.96e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	3.77e-06	4.9e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CD—obesity	3.76e-06	4.89e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HTR2A—obesity	3.76e-06	4.89e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SREBF1—obesity	3.75e-06	4.89e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ESR1—obesity	3.75e-06	4.88e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—C3—obesity	3.75e-06	4.88e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PIK3CA—obesity	3.72e-06	4.84e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SERPINE1—obesity	3.72e-06	4.83e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PRKCB—obesity	3.71e-06	4.82e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—F2—obesity	3.71e-06	4.82e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—BAD—obesity	3.66e-06	4.77e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GOT2—obesity	3.65e-06	4.75e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TYK2—obesity	3.61e-06	4.7e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	3.6e-06	4.69e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RHOA—obesity	3.58e-06	4.66e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—FASN—obesity	3.57e-06	4.65e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IRS2—obesity	3.57e-06	4.64e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AGT—obesity	3.56e-06	4.64e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—BCHE—obesity	3.56e-06	4.63e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3R1—obesity	3.55e-06	4.62e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NOS3—obesity	3.55e-06	4.62e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CG—obesity	3.55e-06	4.62e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IRS1—obesity	3.51e-06	4.56e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—LEP—obesity	3.49e-06	4.54e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APOE—obesity	3.49e-06	4.54e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CAV1—obesity	3.46e-06	4.5e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APOA1—obesity	3.45e-06	4.49e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP2E1—obesity	3.43e-06	4.47e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NQO1—obesity	3.4e-06	4.42e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PIK3CA—obesity	3.38e-06	4.4e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—POMC—obesity	3.38e-06	4.39e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—INS—obesity	3.36e-06	4.37e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ESR1—obesity	3.33e-06	4.34e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	3.33e-06	4.33e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCL2—obesity	3.3e-06	4.3e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	3.29e-06	4.29e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PRKCB—obesity	3.29e-06	4.28e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—F2—obesity	3.29e-06	4.28e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CB—obesity	3.27e-06	4.26e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MTOR—obesity	3.27e-06	4.26e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GCG—obesity	3.26e-06	4.24e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SLC2A4—obesity	3.26e-06	4.24e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—BAD—obesity	3.25e-06	4.23e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IGF1—obesity	3.25e-06	4.23e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AKT2—obesity	3.25e-06	4.22e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYCS—obesity	3.21e-06	4.18e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GGT1—obesity	3.15e-06	4.1e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GOT1—obesity	3.15e-06	4.1e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CG—obesity	3.15e-06	4.1e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CD—obesity	3.12e-06	4.06e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IRS1—obesity	3.11e-06	4.05e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NCOA1—obesity	3.11e-06	4.04e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CA—obesity	3.09e-06	4.02e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SERPINE1—obesity	3.08e-06	4.01e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP19A1—obesity	3.06e-06	3.98e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—STK11—obesity	3.06e-06	3.98e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—AKT1—obesity	3.04e-06	3.96e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TYK2—obesity	3e-06	3.9e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—POMC—obesity	3e-06	3.9e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL6—obesity	2.99e-06	3.89e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—INS—obesity	2.98e-06	3.88e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RHOA—obesity	2.98e-06	3.87e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3R1—obesity	2.94e-06	3.83e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NOS3—obesity	2.94e-06	3.83e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCL2—obesity	2.93e-06	3.82e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF1—obesity	2.88e-06	3.75e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKT2—obesity	2.88e-06	3.75e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MMP9—obesity	2.85e-06	3.7e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—COMT—obesity	2.85e-06	3.7e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PPARGC1A—obesity	2.81e-06	3.65e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GNB3—obesity	2.81e-06	3.65e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CA—obesity	2.8e-06	3.65e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HMOX1—obesity	2.79e-06	3.63e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CD—obesity	2.77e-06	3.6e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK8—obesity	2.77e-06	3.6e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—AKT1—obesity	2.76e-06	3.59e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	2.74e-06	3.57e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SERPINE1—obesity	2.74e-06	3.56e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GNAS—obesity	2.73e-06	3.55e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CB—obesity	2.72e-06	3.54e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MTOR—obesity	2.72e-06	3.54e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOB—obesity	2.68e-06	3.48e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TYK2—obesity	2.66e-06	3.47e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RHOA—obesity	2.64e-06	3.44e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3R1—obesity	2.62e-06	3.4e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NOS3—obesity	2.62e-06	3.4e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—LPL—obesity	2.55e-06	3.32e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—STAT3—obesity	2.53e-06	3.29e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—AKT1—obesity	2.52e-06	3.28e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GPX1—obesity	2.49e-06	3.24e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CA—obesity	2.49e-06	3.24e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL6—obesity	2.48e-06	3.23e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CA—obesity	2.45e-06	3.18e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CD36—obesity	2.43e-06	3.16e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MTOR—obesity	2.41e-06	3.14e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CB—obesity	2.41e-06	3.14e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MMP9—obesity	2.36e-06	3.07e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MYC—obesity	2.35e-06	3.06e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TGFB1—obesity	2.35e-06	3.05e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—MTHFR—obesity	2.3e-06	2.99e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK8—obesity	2.3e-06	2.99e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—AKT1—obesity	2.29e-06	2.98e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PPARA—obesity	2.26e-06	2.94e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—AKT1—obesity	2.24e-06	2.92e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL6—obesity	2.21e-06	2.87e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AGT—obesity	2.19e-06	2.84e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOE—obesity	2.14e-06	2.79e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CAV1—obesity	2.12e-06	2.76e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOA1—obesity	2.12e-06	2.75e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—STAT3—obesity	2.1e-06	2.73e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MMP9—obesity	2.1e-06	2.73e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK8—obesity	2.04e-06	2.66e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—AKT1—obesity	2.04e-06	2.65e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.03e-06	2.64e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—AKT1—obesity	2e-06	2.6e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CA—obesity	2e-06	2.6e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MYC—obesity	1.95e-06	2.54e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TGFB1—obesity	1.95e-06	2.53e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CG—obesity	1.93e-06	2.51e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—STAT3—obesity	1.87e-06	2.43e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PPARG—obesity	1.87e-06	2.43e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—POMC—obesity	1.84e-06	2.39e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—INS—obesity	1.83e-06	2.38e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL6—obesity	1.77e-06	2.3e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MYC—obesity	1.73e-06	2.26e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TGFB1—obesity	1.73e-06	2.25e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CD—obesity	1.7e-06	2.21e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALB—obesity	1.68e-06	2.18e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CA—obesity	1.66e-06	2.16e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AKT1—obesity	1.63e-06	2.12e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3R1—obesity	1.6e-06	2.09e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NOS3—obesity	1.6e-06	2.09e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CB—obesity	1.48e-06	1.93e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CA—obesity	1.47e-06	1.91e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTGS2—obesity	1.47e-06	1.91e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL6—obesity	1.47e-06	1.91e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AKT1—obesity	1.35e-06	1.76e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL6—obesity	1.3e-06	1.7e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKT1—obesity	1.2e-06	1.56e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CA—obesity	9.03e-07	1.17e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AKT1—obesity	7.37e-07	9.6e-06	CbGpPWpGaD
